Forbes -
22 May 2014 19:01
In trading on Thursday, the SPDR S&P Biotech ETF (XBI) is outperforming other ETFs, up about 3.6% on the day. Components of that ETF showing particular strength include shares of Cell Therapeutics (CTIC), up about 16.9% and shares of Isis Pharmaceuticals (ISIS), up about 12.3% on the day.
Share this Article
Comment on this Article
Please to comment